Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report.
Amyloidosis
Birefringence
Congo red
Light and heavy chain deposition disease
Mass spectrometry
Nephrotic syndrome
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
26 06 2023
26 06 2023
Historique:
received:
30
12
2022
accepted:
18
05
2023
medline:
28
6
2023
pubmed:
27
6
2023
entrez:
26
6
2023
Statut:
epublish
Résumé
Light and heavy chain deposition disease (LHCDD) is a rare condition characterised by the deposition of immunoglobulin components in the kidneys. Similarly, Amyloidosis is also caused by the deposition of light chain and/or heavy chain components of immunoglobulins which are folded into amyloid fibrils characterised by Congophilic deposits that exhibit apple-green birefringence under polarised light. Only a handful of reports describing LHCDD with amyloid fibril deposition have been previously published, however, none have characterized the composition of the deposited immunoglobulin components via mass spectrometry. We report a case of a 79-year-old Japanese woman with nephrotic syndrome. Bone marrow aspiration revealed a slight proliferation of plasma cells (under 10%). Immunofluorescence assessment of renal biopsy showed amyloid-like deposits in the glomerulus that were positive for IgA and kappa. Further, the Congo red staining of the deposits was faintly positive, and only a slight birefringence was detected. Electron microscopy confirmed fine fibrillar structures and non-amyloid deposits. Finally, mass spectrometry revealed that the deposits were composed of abundant amounts of light chain with small amounts of heavy chain. Therefore, the patient was diagnosed with LHCDD and focal amyloid deposition. Chemotherapy was subsequently initiated, which resulted in haematological and renal response. Under polarised light, faint birefringence with Congo red staining and periodic acid-methenamine silver positivity indicated that the deposits were mostly non-amyloid fibrils with a small component of amyloid fibrils. Generally, the diagnosis of heavy- and light-chain amyloidosis is defined by greater heavy chain deposition compared to the light chain. However, in our case, contrary to the definition, the light-chain deposition was far greater than that of the heavy-chain. This is the first case of LHCDD with focal amyloid deposition diagnosed by analysing the glomerular deposits by mass spectrometry.
Sections du résumé
BACKGROUND
Light and heavy chain deposition disease (LHCDD) is a rare condition characterised by the deposition of immunoglobulin components in the kidneys. Similarly, Amyloidosis is also caused by the deposition of light chain and/or heavy chain components of immunoglobulins which are folded into amyloid fibrils characterised by Congophilic deposits that exhibit apple-green birefringence under polarised light. Only a handful of reports describing LHCDD with amyloid fibril deposition have been previously published, however, none have characterized the composition of the deposited immunoglobulin components via mass spectrometry.
CASE PRESENTATION
We report a case of a 79-year-old Japanese woman with nephrotic syndrome. Bone marrow aspiration revealed a slight proliferation of plasma cells (under 10%). Immunofluorescence assessment of renal biopsy showed amyloid-like deposits in the glomerulus that were positive for IgA and kappa. Further, the Congo red staining of the deposits was faintly positive, and only a slight birefringence was detected. Electron microscopy confirmed fine fibrillar structures and non-amyloid deposits. Finally, mass spectrometry revealed that the deposits were composed of abundant amounts of light chain with small amounts of heavy chain. Therefore, the patient was diagnosed with LHCDD and focal amyloid deposition. Chemotherapy was subsequently initiated, which resulted in haematological and renal response. Under polarised light, faint birefringence with Congo red staining and periodic acid-methenamine silver positivity indicated that the deposits were mostly non-amyloid fibrils with a small component of amyloid fibrils. Generally, the diagnosis of heavy- and light-chain amyloidosis is defined by greater heavy chain deposition compared to the light chain. However, in our case, contrary to the definition, the light-chain deposition was far greater than that of the heavy-chain.
CONCLUSIONS
This is the first case of LHCDD with focal amyloid deposition diagnosed by analysing the glomerular deposits by mass spectrometry.
Identifiants
pubmed: 37365566
doi: 10.1186/s12882-023-03207-0
pii: 10.1186/s12882-023-03207-0
pmc: PMC10294544
doi:
Substances chimiques
Congo Red
3U05FHG59S
Immunoglobulins
0
Amyloid
0
Immunoglobulin Light Chains
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
187Informations de copyright
© 2023. The Author(s).
Références
Arch Pathol Lab Med. 2007 Jun;131(6):850-1
pubmed: 17550310
BMC Nephrol. 2018 Nov 22;19(1):337
pubmed: 30466387
Blood. 2014 Oct 9;124(15):2325-32
pubmed: 25115890
Blood. 2017 Jan 19;129(3):299-306
pubmed: 27856462
Clin J Am Soc Nephrol. 2020 Mar 6;15(3):404-411
pubmed: 31636087
Lancet Oncol. 2016 Aug;17(8):e328-e346
pubmed: 27511158
Mol Cell Proteomics. 2005 Sep;4(9):1265-72
pubmed: 15958392
Nephrol Dial Transplant. 2015 Jul;30(7):1151-5
pubmed: 25796445
Intern Med. 2005 Sep;44(9):970-4
pubmed: 16258214
Clin Exp Immunol. 1980 Dec;42(3):545-53
pubmed: 6783355
Kidney Int. 2013 Mar;83(3):353-6
pubmed: 23446254
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
Kidney Int. 2013 Mar;83(3):463-70
pubmed: 23302715
Am J Kidney Dis. 2010 Nov;56(5):971-6
pubmed: 20870327
Hum Pathol. 1985 May;16(5):477-84
pubmed: 3921452
Clin Exp Nephrol. 2009 Dec;13(6):671-6
pubmed: 19728011
Nephrol Dial Transplant. 1998 Jun;13(6):1438-45
pubmed: 9641173
Mod Pathol. 1997 May;10(5):485-95
pubmed: 9160315
Intern Med. 2017;56(1):61-66
pubmed: 28050001
Am J Pathol. 1995 Aug;147(2):375-85
pubmed: 7639331
Nephron. 1989;52(2):139-43
pubmed: 2500613